YAWATA NOBUYO

ヤワタノブヨ | YAWATA NOBUYO

Affiliation and department：
Research theme for competitive and other funds (7)：

2022 - 2025 網膜変性を促進する末梢血免疫細胞サブセットの同定とこれらを標的とした治療開発
2021 - 2024 Elucidation of mechanism of the tumor microenvironment in the eyes in vitreoretinal lymphoma
2021 - 2024 Investigation of local immunopathogenesis in human ocular inflammatory diseases by advanced approach
2021 - 2024 新規遺伝性自己炎症性疾患:ROSAH症候群(ALPK1変異)の病態解析と治療確立
2021 - 2023 眼炎症疾患診断を可能とするin vivoシングルセルイメージング技術の開発

Show all

Papers (36)：

Chihiro Fukui, Satoshi Yamana, Yanqi Xue, Mariko Shirane, Hiroki Tsutsui, Kenichiro Asahara, Keiko Yoshitomi, Takako Ito, Tantri Lestari, Eiichi Hasegawa, et al. Functions of mucosal associated invariant T cells in eye diseases. Frontiers in Immunology. 2024. 15
Yosuke Fukuda, Nobuyo Yawata, Eiichi Hasegawa, Satoshi Yamana, Mariko Shirane, Takako Ito, Atsunobu Takeda, Motoshi Sonoda, Katsuhide Eguchi, Masataka Ishimura, et al. Clinical Features of Pediatric Uveitis at a Tertiary Referral Center in the Western Region of Japan. Ocular immunology and inflammation. 2023. 1-7
Satoshi Yamana, Eiichi Hasegawa, Atsunobu Takeda, Nobuyo Yawata, Koh-Hei Sonoda. Long-term outcomes of infliximab in patients with Behçet's disease-associated uveitis. International ophthalmology. 2023. 43. 3. 937-944
Mariko Shirane, Nobuyo Yawata, Daisuke Motooka, Kensuke Shibata, Seik Soon Khor, Yosuke Omae, Toshikatsu Kaburaki, Ryoji Yanai, Hisashi Mashimo, Satoshi Yamana, et al. Corrigendum: Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance(Front. Immunol., (2022), 13, (1008220), 10.3389/fimmu.2022.1008220). Frontiers in Immunology. 2023. 13
Mariko Shirane, Nobuyo Yawata, Daisuke Motooka, Kensuke Shibata, Seik-Soon Khor, Yosuke Omae, Toshikatsu Kaburaki, Ryoji Yanai, Hisashi Mashimo, Satoshi Yamana, et al. Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance. Frontiers in immunology. 2022. 13. 1008220-1008220

ｍore...

MISC (1)：

白根茉利子, 八幡信代, 元岡大祐, 柴田健輔, Khor Seik-Soon, 大前陽輔, 柳井亮二, 眞下永, 蕪城俊克, 森康雄, et al. サイトメガロウイルス(CMV)眼感染症眼内液とCMV血症末梢血のCMV UL40多型の違いと眼内への感染進展における意義. 日本臨床免疫学会総会プログラム・抄録集. 2022. 50回. 76-76

Books (1)：

NK cell KIR heterogeneity and evolution
Elsevier Ltd 2010

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page